EJVES Extra
Volume 13, Issue 6 , Pages 87-89 , June 2007

Anaphylaxis Following Foam Sclerotherapy: A Life Threatening Complication of Non Invasive Treatment For Varicose Veins

,Accepted 24 February 2007.

References 

  1. Coleridge-Smith P. Saphenous ablation: sclerosant or sclerofoam?. Semin Vasc Surg. 2005;18(1):19–24
  2. Breu FX, Guggenbichler S. European consensus meeting on foam sclerotherapy. [April, 4–6, 2003, Tegernsee, Germany] Dermatol Surg. 2004;30:709–717
  3. Beale RJ, Gough MJ. Treatment options for primary varicose veins- a review. Eur J Vasc Endovasc Surg. 2005;30:83–95
  4. Fegan WG. Compression sclerotherapy. In: Varicose veins: compression sclerotherapy. William Heinemann Med Books; 1967;Available at: http://www.fegan.com/cs/Chapter%252520VI.htm[accessed 19/01/07]
  5. STD Pharmaceutical Products Ltd . Fibro-vein-prescribing-information. Available at: http://www.fibro-vein.co.uk/content/Fibro-Vein-Prescribing-Information.pdf[accessed 19/01/07]
  6. Jia X, Mowatt G, Ho V, Cook J, Fraser C, Burr J. A systematic review on the safety and efficacy of foam sclerotherapy for venous disease of the lower limbs. Nov 2006; Commissioned by the National Institute for Clinical Excellence (NICE). Available at: http://www.nice.org.uk/docref.aspx?o=ip244review[accessed 30/01/07]
  7. Galland RB, Magee TR, Lewis MH. A survey of current attitudes of British and Irish vascular surgeons to venous sclerotherapy. Eur J Vasc Endovasc Surg. 1998;16:43–46

☆ The authors have no commercial, proprietary, or financial interest in any products or companies described in this article.

PII: S1533-3167(07)00010-6

doi: 10.1016/j.ejvsextra.2007.02.005

EJVES Extra
Volume 13, Issue 6 , Pages 87-89 , June 2007

Article Tools

* Image Usage & Resolution